Net Cash Provided by (Used in) Financing Activities of ACCENDRA HEALTH INC/VA/ from 31 Mar 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ACCENDRA HEALTH INC/VA/ annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2012 to 31 Dec 2025.
  • ACCENDRA HEALTH INC/VA/ Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $92,778,000, a 74% increase year-over-year.
  • ACCENDRA HEALTH INC/VA/ annual Net Cash Provided by (Used in) Financing Activities for 2025 was $188,078,000.
  • ACCENDRA HEALTH INC/VA/ annual Net Cash Provided by (Used in) Financing Activities for 2024 was $267,603,000, a 36% increase from 2023.
  • ACCENDRA HEALTH INC/VA/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $417,330,000, a 128% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $188,078,000 +$455,681,000 01 Jan 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
2024 $267,603,000 +$149,727,000 +36% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
2023 $417,330,000 -$1,914,435,000 -128% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
2022 $1,497,105,000 +$1,626,583,000 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $129,478,000 +$249,908,000 +66% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $379,386,000 -$249,189,000 -191% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $130,197,000 -$831,268,000 -119% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $701,071,000 +$428,265,000 +157% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
2017 $272,806,000 +$415,510,000 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $142,704,000 -$17,825,000 -14% 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2019 2018 FY
2015 $124,879,000 -$403,439,000 -145% 01 Jan 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
2014 $278,560,000 +$360,540,000 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $81,980,000 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY

ACCENDRA HEALTH INC/VA/ Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $92,778,000 +$39,458,000 +74% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $53,320,000 +$180,809,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $127,489,000 -$1,791,683,000 -108% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q1 2022 $1,664,194,000 +$1,744,588,000 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $80,394,000 -$48,988,000 -156% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $31,406,000 -$80,911,000 -163% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $49,505,000 +$71,308,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $21,803,000 -$3,304,000 -18% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $18,499,000 -$2,183,000 -13% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $16,316,000 +$34,098,000 +68% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $50,414,000 -$49,622,000 -6265% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2014 $792,000 +$16,648,000 +95% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015 2015 Q1
Q1 2013 $17,440,000 -$1,809,000 -12% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q1 2012 $15,631,000 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.